Literature DB >> 31608404

Natural history of excessive daytime sleepiness: a population-based 5-year longitudinal study.

I Jaussent1, C M Morin2, H Ivers2, Y Dauvilliers1,3.   

Abstract

STUDY
OBJECTIVES: To document the rates of persistent, remitted, and intermittent excessive daytime sleepiness (EDS) in a longitudinal 5-year community study of adults and to assess how changes in risk factors over time can predict improvement of daytime sleepiness (DS).
METHODS: Participants were recruited in 2007-2008 as part of a population-based epidemiological study implemented in Canada. They completed postal assessments at baseline and at each yearly follow-up. An Epworth Sleepiness Scale total score >10 indicated clinically significant EDS; a 4-point reduction between two consecutive evaluations defined DS improvement. Socio-demographic, lifestyle, health characteristics, and sleep-related measures (e.g. insomnia symptoms, sleep duration, sleep medication) were self-reported at each time point. Cox proportional-hazard models were used to predict EDS and DS remissions over 5 years.
RESULTS: Among the 2167 participants, 33% (n = 714) met criteria for EDS at baseline, of whom 33% had persistent EDS, 44% intermittent EDS, and 23% remitted EDS over the follow-up. Furthermore, 61.4% of 2167 initial participants had stable DS, 27.1% sustained DS improvement and 8.5% transient improvement over the follow-up. The main predictors of EDS remission or DS improvement were normal weight, taking less hypnotics, having hypertension, increased nighttime sleep duration, and decreased insomnia, and depressive symptoms.
CONCLUSIONS: EDS waxes and wanes over time with frequent periods of remission and is influenced by behavioral characteristics and changes in psychological, metabolic, and nighttime sleep patterns. Targeting these predictors in future interventions is crucial to reduce DS in the general adult population. © Sleep Research Society 2019. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  chronic; cohort studies; disease; epidemiology; insomnia; natural history; psychological factors; remission; sleepiness

Mesh:

Year:  2020        PMID: 31608404      PMCID: PMC7066486          DOI: 10.1093/sleep/zsz249

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  28 in total

1.  Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology.

Authors:  Maurice M Ohayon; Yves Dauvilliers; Charles F Reynolds
Journal:  Arch Gen Psychiatry       Date:  2012-01

2.  Daytime sleepiness and cognitive impairment in the elderly population.

Authors:  Maurice M Ohayon; Marie-Françoise Vecchierini
Journal:  Arch Intern Med       Date:  2002-01-28

3.  Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults.

Authors:  N Breslau; T Roth; L Rosenthal; P Andreski
Journal:  Biol Psychiatry       Date:  1996-03-15       Impact factor: 13.382

4.  Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group.

Authors: 
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

5.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

6.  Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.

Authors:  Yves Dauvilliers; Claudio Bassetti; Gert Jan Lammers; Isabelle Arnulf; Geert Mayer; Andrea Rodenbeck; Philippe Lehert; Claire-Li Ding; Jeanne-Marie Lecomte; Jean-Charles Schwartz
Journal:  Lancet Neurol       Date:  2013-10-07       Impact factor: 44.182

7.  Excessive sleepiness is predictive of cognitive decline in the elderly.

Authors:  Isabelle Jaussent; Jean Bouyer; Marie-Laure Ancelin; Claudine Berr; Alexandra Foubert-Samier; Karen Ritchie; Maurice M Ohayon; Alain Besset; Yves Dauvilliers
Journal:  Sleep       Date:  2012-09-01       Impact factor: 5.849

8.  Excessive sleep duration and quality of life.

Authors:  Maurice M Ohayon; Charles F Reynolds; Yves Dauvilliers
Journal:  Ann Neurol       Date:  2013-07-11       Impact factor: 10.422

Review 9.  Evaluation of the measurement properties of the Epworth sleepiness scale: a systematic review.

Authors:  Tetyana B Kendzerska; Peter M Smith; Romina Brignardello-Petersen; Richard S Leung; George A Tomlinson
Journal:  Sleep Med Rev       Date:  2013-08-22       Impact factor: 11.609

10.  Insomnia, daytime sleepiness and cardio-cerebrovascular diseases in the elderly: a 6-year prospective study.

Authors:  Isabelle Jaussent; Jean-Philippe Empana; Marie-Laure Ancelin; Alain Besset; Catherine Helmer; Christophe Tzourio; Karen Ritchie; Jean Bouyer; Yves Dauvilliers
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more
  4 in total

Review 1.  Sleep Deficiency: A Symptoms Perspective: Exemplars from Chronic Heart Failure, Inflammatory Bowel Disease, and Breast Cancer.

Authors:  Nancy S Redeker; Samantha Conley; Youri Hwang
Journal:  Clin Chest Med       Date:  2022-06       Impact factor: 4.967

2.  Association of Excessive Daytime Sleepiness with Cerebral Small Vessel Disease in Community-Dwelling Older Adults.

Authors:  Jing Zhao; Qianqian Kong; Minghuan Wang; Hao Huang; Xirui Zhou; Yinping Guo; Yi Zhang; Lingshan Wu; Zhiyuan Yu; Xiang Luo
Journal:  Nat Sci Sleep       Date:  2022-04-21

3.  Cross Sectional Study of the Community Self-Reported Risk of Obstructive Sleep Apnoea (OSA) and Awareness in Thessaly, Greece.

Authors:  Petros Kassas; Georgios D Vavougios; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Clocks Sleep       Date:  2022-02-10

4.  Prevalent and sex-biased breathing patterns modify functional connectivity MRI in young adults.

Authors:  Charles J Lynch; Benjamin M Silver; Marc J Dubin; Alex Martin; Henning U Voss; Rebecca M Jones; Jonathan D Power
Journal:  Nat Commun       Date:  2020-10-20       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.